Embecta (FRA:JX7) Interest Expense : €-102 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Embecta Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Embecta's interest expense for the three months ended in Mar. 2024 was € -26 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was €-102 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Embecta's Operating Income for the three months ended in Mar. 2024 was € 36 Mil. Embecta's Interest Expense for the three months ended in Mar. 2024 was € -26 Mil. Embecta's Interest Coverage for the quarter that ended in Mar. 2024 was 1.41. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Embecta Interest Expense Historical Data

The historical data trend for Embecta's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Interest Expense Chart

Embecta Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

Interest Expense

-46.66

-100.26

Embecta Quarterly Data
	Sep19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial											-25.03	-24.92	-25.86	-25.40	-25.58

Embecta Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-102 Mil.

Embecta (FRA:JX7) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Embecta's Interest Expense for the three months ended in Mar. 2024 was €-26 Mil. Its Operating Income for the three months ended in Mar. 2024 was €36 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was €1,493 Mil.

Embecta's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	36.064	/	-25.576
	=	1.41

The higher the ratio, the stronger the company's financial strength is.

Embecta (FRA:JX7) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

EMBC:USA JX7:Germany

Address

300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054

Website

https://www.embecta.com

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Embecta (FRA:JX7) Headlines

No Headlines